Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2004 Filed Feb 24, 2004 21:25 UTC |
NEMMERS JOSEPH MSenior Vice President
|
GrantCommon shares without par value | 8,000 | $43.66 | $349,280.00 |
DisclosureSEC source: 0001104659-04-005613 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,571 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:04 UTC |
BEGLEY CHRISTOPHER BSenior Vice President
|
GrantOption (right to buy) · Derivative | 26,381 | $0.00 Strike: $44.31 | $0.00 |
DisclosureSEC source: 0001104659-04-005011 · a4.xml · derivative · entry 5 BEGLEY CHRISTOPHER B · CIK 0001239420 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,381 Underlying: common shares · 26,381 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:04 UTC |
BEGLEY CHRISTOPHER BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 29,999 | $0.00 Strike: $35.36 | $0.00 |
DisclosureSEC source: 0001104659-04-005011 · a4.xml · derivative · entry 4 BEGLEY CHRISTOPHER B · CIK 0001239420 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,001 Underlying: common shares · 29,999 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:04 UTC |
BEGLEY CHRISTOPHER BSenior Vice President
|
Tax withholdingCommon shares without par value | 26,381 | $44.31 | $1,168,942.11 |
DisclosureSEC source: 0001104659-04-005011 · a4.xml · nonDerivative · entry 2 BEGLEY CHRISTOPHER B · CIK 0001239420 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,124 Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:04 UTC |
BEGLEY CHRISTOPHER BSenior Vice President
|
Exercise / conversionCommon shares without par value | 29,999 | $35.36 | $1,060,764.64 |
DisclosureSEC source: 0001104659-04-005011 · a4.xml · nonDerivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:04 UTC |
DE LASA JOSE MSenior Vice President
|
GrantOption (right to buy · Derivative | 26,372 | $0.00 Strike: $44.31 | $0.00 |
DisclosureSEC source: 0001104659-04-005012 · a4.xml · derivative · entry 5 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,372 Underlying: common shares · 26,372 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:04 UTC |
DE LASA JOSE MSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 29,999 | $0.00 Strike: $35.36 | $0.00 |
DisclosureSEC source: 0001104659-04-005012 · a4.xml · derivative · entry 4 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,001 Underlying: common shares · 29,999 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:04 UTC |
DE LASA JOSE MSenior Vice President
|
Tax withholdingCommon shares without par value | 26,372 | $44.31 | $1,168,543.32 |
DisclosureSEC source: 0001104659-04-005012 · a4.xml · nonDerivative · entry 2 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,929 Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:04 UTC |
DE LASA JOSE MSenior Vice President
|
Exercise / conversionCommon shares without par value | 29,999 | $35.36 | $1,060,764.64 |
DisclosureSEC source: 0001104659-04-005012 · a4.xml · nonDerivative · entry 1 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:05 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
GrantOption (right to buy) · Derivative | 29,296 | $0.00 Strike: $44.31 | $0.00 |
DisclosureSEC source: 0001104659-04-005013 · a4.xml · derivative · entry 5 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,296 Underlying: common shares · 29,296 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:05 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 33,333 | $0.00 Strike: $35.36 | $0.00 |
DisclosureSEC source: 0001104659-04-005013 · a4.xml · derivative · entry 4 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,667 Underlying: common shares · 33,333 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:05 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
Tax withholdingCommon shares without par value | 29,296 | $44.31 | $1,298,105.76 |
DisclosureSEC source: 0001104659-04-005013 · a4.xml · nonDerivative · entry 2 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,916 Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:05 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
Exercise / conversionCommon shares without par value | 33,333 | $35.36 | $1,178,654.88 |
DisclosureSEC source: 0001104659-04-005013 · a4.xml · nonDerivative · entry 1 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,212 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:05 UTC |
LEIDEN JEFFREY MDirector · President & COO
|
GrantOption (right to buy) · Derivative | 11,800 | $0.00 Strike: $44.31 | $0.00 |
DisclosureSEC source: 0001104659-04-005014 · a4.xml · derivative · entry 5 LEIDEN JEFFREY M · CIK 0001242825 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,800 Underlying: common shares · 11,800 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:05 UTC |
LEIDEN JEFFREY MDirector · President & COO
|
Exercise / conversionOption (right to buy) · Derivative | 13,444 | $0.00 Strike: $35.36 | $0.00 |
DisclosureSEC source: 0001104659-04-005014 · a4.xml · derivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436,556 Underlying: common shares · 13,444 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:05 UTC |
LEIDEN JEFFREY MDirector · President & COO
|
Tax withholdingCommon shares without par value | 11,800 | $44.31 | $522,858.00 |
DisclosureSEC source: 0001104659-04-005014 · a4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,992 Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:05 UTC |
LEIDEN JEFFREY MDirector · President & COO
|
Exercise / conversionCommon shares without par value | 13,444 | $35.36 | $475,379.84 |
DisclosureSEC source: 0001104659-04-005014 · a4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:06 UTC |
FREYMAN THOMAS CSenior Vice President
|
GrantOption (right to buy) · Derivative | 29,257 | $0.00 Strike: $44.31 | $0.00 |
DisclosureSEC source: 0001104659-04-005015 · a4.xml · derivative · entry 6 FREYMAN THOMAS C · CIK 0001239126 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,257 Underlying: common shares · 29,257 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:06 UTC |
FREYMAN THOMAS CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 33,333 | $0.00 Strike: $35.36 | $0.00 |
DisclosureSEC source: 0001104659-04-005015 · a4.xml · derivative · entry 5 FREYMAN THOMAS C · CIK 0001239126 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,667 Underlying: common shares · 33,333 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:06 UTC |
FREYMAN THOMAS CSenior Vice President
|
Tax withholdingCommon shares without par value | 29,257 | $44.31 | $1,296,377.67 |
DisclosureSEC source: 0001104659-04-005015 · a4.xml · nonDerivative · entry 3 FREYMAN THOMAS C · CIK 0001239126 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,237 Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:06 UTC |
FREYMAN THOMAS CSenior Vice President
|
Exercise / conversionCommon shares without par value | 33,333 | $35.36 | $1,178,654.88 |
DisclosureSEC source: 0001104659-04-005015 · a4.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:06 UTC |
WYATT LANCE BSenior Vice President
|
GrantOption (right to buy) · Derivative | 26,384 | $0.00 Strike: $44.31 | $0.00 |
DisclosureSEC source: 0001104659-04-005016 · a4.xml · derivative · entry 5 WYATT LANCE B · CIK 0001239421 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,384 Underlying: common shares · 26,384 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:06 UTC |
WYATT LANCE BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 29,999 | $0.00 Strike: $35.36 | $0.00 |
DisclosureSEC source: 0001104659-04-005016 · a4.xml · derivative · entry 4 WYATT LANCE B · CIK 0001239421 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,001 Underlying: common shares · 29,999 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:06 UTC |
WYATT LANCE BSenior Vice President
|
Tax withholdingCommon shares without par value | 26,384 | $44.31 | $1,169,075.04 |
DisclosureSEC source: 0001104659-04-005016 · a4.xml · nonDerivative · entry 2 WYATT LANCE B · CIK 0001239421 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,527 Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:06 UTC |
WYATT LANCE BSenior Vice President
|
Exercise / conversionCommon shares without par value | 29,999 | $35.36 | $1,060,764.64 |
DisclosureSEC source: 0001104659-04-005016 · a4.xml · nonDerivative · entry 1 WYATT LANCE B · CIK 0001239421 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Feb 19, 2004 20:28 UTC |
LINDER GREG WVice President
|
GrantOption (right to buy) · Derivative | 13,875 | $0.00 Strike: $44.31 | $0.00 |
DisclosureSEC source: 0001104659-04-005168 · a4.xml · derivative · entry 7 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,875 Underlying: Common shares · 13,875 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 17, 2004 Filed Feb 19, 2004 20:28 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 15,724 | $0.00 Strike: $35.36 | $0.00 |
DisclosureSEC source: 0001104659-04-005168 · a4.xml · derivative · entry 6 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,276 Underlying: Common shares · 15,724 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Feb 19, 2004 20:28 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,960 | $0.00 Strike: $14.32 | $0.00 |
DisclosureSEC source: 0001104659-04-005168 · a4.xml · derivative · entry 5 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,960 shares Expires 2004-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Feb 19, 2004 20:28 UTC |
LINDER GREG WVice President
|
Tax withholdingCommon shares without par value | 14,508 | $44.31 | $642,849.48 |
DisclosureSEC source: 0001104659-04-005168 · a4.xml · nonDerivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,997 Read SEC document |
| February 17, 2004 Filed Feb 19, 2004 20:28 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 15,724 | $35.36 | $556,000.64 |
DisclosureSEC source: 0001104659-04-005168 · a4.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Feb 19, 2004 20:28 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 1,960 | $14.32 | $28,067.20 |
DisclosureSEC source: 0001104659-04-005168 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2004 Filed Feb 13, 2004 21:50 UTC |
WASCOE THOMAS MSenior Vice President
|
Tax withholdingCommon shares without par value | 7,949 | $44.07 | $350,312.43 |
DisclosureSEC source: 0001104659-04-004340 · a4.xml · nonDerivative · entry 1 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,549 Read SEC document |
| February 12, 2004 Filed Feb 17, 2004 16:47 UTC Amendment |
WASCOE THOMAS MSenior Vice President
|
Tax withholdingCommon shares without par value | 7,949 | $44.07 | $350,312.43 |
DisclosureSEC source: 0001104659-04-004635 · a4a.xml · nonDerivative · entry 1 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,549 Read SEC document |
| February 06, 2004 Filed Feb 10, 2004 20:44 UTC |
DE LASA JOSE MSenior Vice President
|
SaleCommon shares without par value | 48,000 | $44.25 | $2,124,038.40 |
DisclosureSEC source: 0001104659-04-003280 · a4.xml · nonDerivative · entry 4 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,302 Read SEC document |
| January 30, 2004 Filed Feb 10, 2004 20:44 UTC |
DE LASA JOSE MSenior Vice President
|
GiftCommon shares without par value | 490 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-04-003280 · a4.xml · nonDerivative · entry 3 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,302 Read SEC document |
| January 26, 2004 Filed Jan 28, 2004 21:35 UTC |
GONZALEZ RICHARD ADirector · Chief Operating Officer
|
SaleCommon shares without par value | 11,880 | $43.50 | $516,780.00 |
DisclosureSEC source: 0001104659-04-001974 · a4.xml · nonDerivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,688 Read SEC document |
| January 26, 2004 Filed Feb 18, 2004 23:06 UTC |
FREYMAN THOMAS CSenior Vice President
|
GiftCommon shares without par value | 562 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-04-005015 · a4.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,161 Read SEC document |
| January 22, 2004 Filed Jan 26, 2004 22:23 UTC |
FREYMAN THOMAS CSenior Vice President
|
GrantOption (right to buy) · Derivative | 23,199 | $0.00 Strike: $43.70 | $0.00 |
DisclosureSEC source: 0001104659-04-001715 · a4.xml · derivative · entry 8 FREYMAN THOMAS C · CIK 0001239126 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,199 Underlying: Common shares · 23,199 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 22, 2004 Filed Jan 26, 2004 22:23 UTC |
FREYMAN THOMAS CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 26,666 | $0.00 Strike: $34.70 | $0.00 |
DisclosureSEC source: 0001104659-04-001715 · a4.xml · derivative · entry 7 FREYMAN THOMAS C · CIK 0001239126 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 26,666 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2004 Filed Jan 26, 2004 22:23 UTC |
FREYMAN THOMAS CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 10,216 | $0.00 Strike: $19.57 | $0.00 |
DisclosureSEC source: 0001104659-04-001715 · a4.xml · derivative · entry 6 FREYMAN THOMAS C · CIK 0001239126 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 10,216 shares Expires 2005-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2004 Filed Jan 26, 2004 22:23 UTC |
FREYMAN THOMAS CSenior Vice President
|
Tax withholdingCommon shares without par value | 27,773 | $43.70 | $1,213,680.10 |
DisclosureSEC source: 0001104659-04-001715 · a4.xml · nonDerivative · entry 4 FREYMAN THOMAS C · CIK 0001239126 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,723 Read SEC document |
| January 22, 2004 Filed Jan 26, 2004 22:23 UTC |
FREYMAN THOMAS CSenior Vice President
|
Exercise / conversionCommon shares without par value | 26,666 | $34.70 | $925,310.20 |
DisclosureSEC source: 0001104659-04-001715 · a4.xml · nonDerivative · entry 3 FREYMAN THOMAS C · CIK 0001239126 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,496 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2004 Filed Jan 26, 2004 22:23 UTC |
FREYMAN THOMAS CSenior Vice President
|
Exercise / conversionCommon shares without par value | 10,216 | $19.57 | $199,927.12 |
DisclosureSEC source: 0001104659-04-001715 · a4.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2003 Filed Dec 31, 2003 22:29 UTC |
WYATT LANCE BSenior Vice President
|
GrantOption (right to buy) · Derivative | 26,048 | $0.00 Strike: $46.57 | $0.00 |
DisclosureSEC source: 0001104659-03-029465 · a4.xml · derivative · entry 5 WYATT LANCE B · CIK 0001239421 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,048 Underlying: common shares · 26,048 shares Expires 2008-02-12 F2 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 31, 2003 Filed Dec 31, 2003 22:29 UTC |
WYATT LANCE BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 30,000 | $0.00 Strike: $37.00 | $0.00 |
DisclosureSEC source: 0001104659-03-029465 · a4.xml · derivative · entry 4 WYATT LANCE B · CIK 0001239421 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 30,000 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2003 Filed Dec 31, 2003 22:29 UTC |
WYATT LANCE BSenior Vice President
|
Tax withholdingCommon shares without par value | 26,048 | $46.57 | $1,213,055.36 |
DisclosureSEC source: 0001104659-03-029465 · a4.xml · nonDerivative · entry 2 WYATT LANCE B · CIK 0001239421 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,912 Read SEC document |
| December 31, 2003 Filed Dec 31, 2003 22:29 UTC |
WYATT LANCE BSenior Vice President
|
Exercise / conversionCommon shares without par value | 30,000 | $37.00 | $1,110,000.00 |
DisclosureSEC source: 0001104659-03-029465 · a4.xml · nonDerivative · entry 1 WYATT LANCE B · CIK 0001239421 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2003 Filed Jan 2, 2004 16:35 UTC |
MCCULLOUGH GARY ESenior Vice President
|
GrantOption (right to buy) · Derivative | 100,000 | $0.00 Strike: $46.62 | $0.00 |
DisclosureSEC source: 0001104659-04-000013 · a4.xml · derivative · entry 2 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common shares · 100,000 shares Expires 2013-12-30 F2 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 33,334, 33,333, and 33,333 beginning on December 31, 2004, the first anniversary date of the grant. Read SEC document |
| December 31, 2003 Filed Jan 2, 2004 16:35 UTC |
MCCULLOUGH GARY ESenior Vice President
|
GrantCommon shares without par value | 40,000 | $46.62 | $1,864,800.00 |
DisclosureSEC source: 0001104659-04-000013 · a4.xml · nonDerivative · entry 1 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| December 31, 2003 Filed Jan 2, 2004 18:07 UTC |
POWELL BOONE JRDirector
|
GrantStock equivalent units · Derivative | 268 | $46.60 Strike: $0.00 | $12,488.80 |
DisclosureSEC source: 0001104659-04-000020 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,978 Underlying: common shares · 268 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.